Answers are grounded in this paper and cite their sources.
Study identifies factors affecting patient decisions to enroll in cancer clinical trials, suggesting implications for trial participation rates.
The development of new cancer therapies requires additional, and more complex, clinical trials. But only approximately 3% to 5% of adult cancer patients participate in cancer clinical trials. This study seeks to identify and understand the attitudes of the public and cancer survivors toward health-related decisions and cancer clinical trials to identify the key factors that must be addressed to increase that percentage.
No takes yet. Share an insight, caveat, or question.
Comis et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: